Atomico Insights
Our take on investment themes, industries and the latest news about the gamechangers we've partnered with.
- Partnerships
1 Aug 2024Our continued investment in Healx: leveraging AI to advance rare disease treatments
Atomico is doubling down on our initial partnership with Healx, the AI-enabled clinical-stage biotech company specialising in treatments for rare diseases, to co-lead their $47m Series C today. This brings Healx’s total capital raised to $115 million.
- Partnerships
28 Mar 2024Our investment in Pelago: doubling down on substance use management
Atomico is once again partnering with Pelago to lead their $58 Million Series C, having co-led their Series B back in 2021.
- Partnerships
20 Sept 2023Our investment in Corti - supporting overburdened healthcare professionals globally
- Partnerships
5 Jul 2023Our partnership with Neko Health: building a proactive healthcare system
- Partnerships
14 Feb 2022Our investment in Gaia: redesigning access to fertility care
- Partnerships
26 Oct 2021Atomico’s take on female and reproductive health in Europe through a consumer lens
- Partnerships
20 Jul 2021Rethinking employee wellness models: Atomico’s investment in Pelago
- Partnerships
19 Jul 2021Our investment in Pelago: tackling addictions with digital solutions
- Partnerships
16 Oct 2019Our Investment in Healx: revolutionising rare disease treatment discovery
- Partnerships
23 Sept 2019Our Investment in Kheiron Medical: giving people a better fighting chance against cancer
- Partnerships
24 Feb 2019Our Investment in accuRx: bringing patients and their healthcare teams together
- Partnerships
24 Jul 2017Our Investment in Hinge Health: how Digital Care for Common Injuries is Transforming Outcomes
